| pubmed-article:16379317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0085957 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0050078 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0184959 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:16379317 | lifeskim:mentions | umls-concept:C0442124 | lld:lifeskim |
| pubmed-article:16379317 | pubmed:issue | 112 | lld:pubmed |
| pubmed-article:16379317 | pubmed:dateCreated | 2005-12-28 | lld:pubmed |
| pubmed-article:16379317 | pubmed:abstractText | Increased 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration has been proposed as reliable marker of the oxidative DNA damage, and prognostication of urological carcinogenesis, particularly in bladder cancer. Widely accepted method of treatment in early stages of bladder cancer is transurethral electro resection (TURN). Intravesical bacillus Calmette-Guerin instillation is considered to be the therapeutic agent for superficial transitional cell carcinoma (TCC) of the bladder and has been established as standard therapy in the patients. The aim of the study was to test the concentration of 8-OHdG in urine in patients with bladder cancer and the effect of TURN and BCG therapy on the 8-OHdG value. | lld:pubmed |
| pubmed-article:16379317 | pubmed:language | pol | lld:pubmed |
| pubmed-article:16379317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16379317 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16379317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16379317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16379317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16379317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16379317 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16379317 | pubmed:issn | 1426-9686 | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:BajZbigniewZ | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:KaczmarekPiot... | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:B?aszczykJanJ | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:NiemirowiczJe... | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:Fija?kowskiPa... | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:Sierakowska-F... | lld:pubmed |
| pubmed-article:16379317 | pubmed:author | pubmed-author:KasprzakAndrz... | lld:pubmed |
| pubmed-article:16379317 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16379317 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:16379317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16379317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16379317 | pubmed:pagination | 526-8 | lld:pubmed |
| pubmed-article:16379317 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:meshHeading | pubmed-meshheading:16379317... | lld:pubmed |
| pubmed-article:16379317 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16379317 | pubmed:articleTitle | [Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation]. | lld:pubmed |
| pubmed-article:16379317 | pubmed:affiliation | Uniwersytet Medyczny w Lodzi, Zak?ad Patofizjologii i Immunologii Klinicznej. | lld:pubmed |
| pubmed-article:16379317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16379317 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16379317 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16379317 | lld:pubmed |
